Patient Dies In Landmark Crispr Study

Terry Horgan, the patient who was undergoing gene editing treatment being conducted by Cure Rare Disease, a Connecticut-based nonprofit founded by his brother, Rich, to try and save him from the fatal condition, died during the landmark Crispr study.

The only participant in a new study employing a gene-editing technique has passed away, and the trial's organisers are now attempting to determine what caused his death.

Terry Horgan, a 27-year-old who had Duchenne muscular dystrophy, die...

Subscribe to view this content.

Explore exclusive GGI coverage of Donald Trump’s assassination attempt.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].